Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01248143
Other study ID # FPP and TEA IN DIABETES
Secondary ID
Status Completed
Phase Phase 2/Phase 3
First received November 24, 2010
Last updated November 14, 2014
Start date November 2010
Est. completion date March 2011

Study information

Verified date November 2014
Source Touro College
Contact n/a
Is FDA regulated No
Health authority Mauritius: Ministry of Health and Quality of Life
Study type Interventional

Clinical Trial Summary

Type 2 diabetes is common in ethnic and, minority groups in developing and developed countries such as Africans, African Americans, Asians, Native Americans, Hispano-Latinos and Alaskan indians. A randomized controlled study to assess the efficacy of fermented papaya preparation and green tea infusates in latent diabetes (individuals newly diagnosed as diabetics) is proposed. Glycation products from excess glucose autooxidation can chemically modify DNA causing mutations and cause complex DNA rearrangements. Advanced glycation end-products which play a role as proinflammatory mediators in gestational diabetes can accelerate vascular occlusion by quenching the vasodilating agent nitric oxide. Interaction with high-affinity receptors located on monocytes and macrophages can enhance the production of free radicals and reactive oxygen/nitrogen species, the secretion of tumor necrosis factor-α, interleukin-1 and insulin-like growth factor I which can proliferate endothelial, mesangial and smooth muscle cells and hence contribute significantly to the pathogenesis of cardiovascular complications. The clinical markers include C-reactive proteins (inflammation indicators), protein C (markers of reno vascular injury), uric acid, natriuretic peptides, and the integrity of isolated adipocytes, glucose levels, lipid indices (triglycerides, total cholesterol, VLDL, HDL and LDL). Given that decreased functional activity of activated protein C affects the permeability of the glomerular capillary wall and enhances apoptosis of glomerular endothelial cells and adipodocytes, this has relevance to the pathophysiology of diabetic nephropathy. A second phase of the study is expected to commence after the first 16 weeks in order to assess the ability of the dietary factors to modulate atheroma formation and the integrity of drug therapy (upon commencement of treatment)on the prognosis of diabetes. This will be expected to last up to 3 years.


Recruitment information / eligibility

Status Completed
Enrollment 300
Est. completion date March 2011
Est. primary completion date March 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 35 Years to 65 Years
Eligibility Inclusion Criteria:

Individuals at risk of diabetes 35-65 years of age male or female

Exclusion Criteria:

- Smokers or those who have stopped smoking 6 months before the study

- Daily alcoholic intake exceeding 4 standard drinks

- Post menopausal women currently under hormone replacement treatment

- Hypertension (>140/90 mm Hg)

- individuals outside the age range 35-60

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Assess the Effect of Fermented Papaya Pretration on Diabetes
  • Assess the Effect of Green Tea on Diabetes
  • Cardiovascular Diseases
  • Diabetes Mellitus
  • Effect of Green Tea and FPP on Atheroma Formation
  • Effects of Green Tea and FPP of Lipid Profiles in Diabetes
  • Effects of Green Tea and FPP on C-reactive Proteins

Intervention

Dietary Supplement:
Green tea
9 gram per day
FPP
2 sachets twice daily

Locations

Country Name City State
Austria University of Vienna Vienna
Mauritius University of Mauritius Reduit
United States Touro College of Pharmacy New York New York

Sponsors (8)

Lead Sponsor Collaborator
Touro College Mauritius Cardiac Center, Mauritius Ministry of Health and Quality of Life, Mauritius Research Council, Osato Research Institute, Societe Uniniere de Bois Cheri, University of Mauritius, University of Vienna

Countries where clinical trial is conducted

United States,  Austria,  Mauritius, 

References & Publications (6)

Aruoma OI, Somanah J, Bourdon E, Rondeau P, Bahorun T. Diabetes as a risk factor to cancer: functional role of fermented papaya preparation as phytonutraceutical adjunct in the treatment of diabetes and cancer. Mutat Res. 2014 Oct;768:60-8. doi: 10.1016/j — View Citation

Bahorun T, Luximon-Ramma A, Gunness TK, Sookar D, Bhoyroo S, Jugessur R, Reebye D, Googoolye K, Crozier A, Aruoma OI. Black tea reduces uric acid and C-reactive protein levels in humans susceptible to cardiovascular diseases. Toxicology. 2010 Nov 28;278(1):68-74. doi: 10.1016/j.tox.2009.11.024. Epub 2009 Dec 4. — View Citation

Bahorun T, Luximon-Ramma A, Neergheen-Bhujun VS, Gunness TK, Googoolye K, Auger C, Crozier A, Aruoma OI. The effect of black tea on risk factors of cardiovascular disease in a normal population. Prev Med. 2012 May;54 Suppl:S98-102. doi: 10.1016/j.ypmed.20 — View Citation

Somanah J, Aruoma OI, Gunness TK, Kowelssur S, Dambala V, Murad F, Googoolye K, Daus D, Indelicato J, Bourdon E, Bahorun T. Effects of a short term supplementation of a fermented papaya preparation on biomarkers of diabetes mellitus in a randomized Maurit — View Citation

Somanah J, Bourdon E, Rondeau P, Bahorun T, Aruoma OI. Relationship between fermented papaya preparation supplementation, erythrocyte integrity and antioxidant status in pre-diabetics. Food Chem Toxicol. 2014 Mar;65:12-7. doi: 10.1016/j.fct.2013.11.050. E — View Citation

Toolsee NA, Aruoma OI, Gunness TK, Kowlessur S, Dambala V, Murad F, Googoolye K, Daus D, Indelicato J, Rondeau P, Bourdon E, Bahorun T. Effectiveness of green tea in a randomized human cohort: relevance to diabetes and its complications. Biomed Res Int. 2 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Assess the effects of green tea and FPP on the levels of C-reactive proteins The pathophysiology of atherosclerosis and other cardiovascular events have associated inflammatory processes. The levels of plasma high-sensitivity (hs) C-Reactive Protein, an acute phase reactant produced in the liver, known to rise in inflammatory reactions are widely suggested to be a predictor of coronary events; and increased uric acid levels (hyperuricemia) are considered to be a risk factor in many clinical conditions including hypertension, cardiovascular events, diabetes mellitus, stroke, and metabolic syndrome. 3 months No
Secondary Assess the effect of green tea and fermented papaya preparation on development of atheroma and drug therapy outcomes Carotid artery angioplasty and stenting has been proposed as an alternative therapy for patients requiring treatment of carotid artery stenosis as opposed to the "gold standard" surgical intervention, carotid endarterectomy. The second phase of the study will investigate the possible role of green tea and fermented papaya preparation in modulating the risk of stroke by assessing the extent of atheroma using both echocardiography and CT angiography. Patients will be on medication and the therapeutic outcome will be assessed. 3 years No